Anzeige
Mehr »
Samstag, 02.05.2026 - Börsentäglich über 12.000 News
Mit Graphen gegen jede Abwehr - Die Zukunft der Drohnen ist da
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Renaissance Capital

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
00:30US IPO Weekly Recap: Biotech, early-stage mining, and Bill Ackman close out the April IPO market
FrUS IPO Week Ahead: May IPO market kicks off with defense tech and soft drinks
FrSPAC CCIS Acquisition withdraws $60 million IPO
FrNeuropsychiatric therapeutics Seaport Therapeutics prices upsized IPO at $18, the high end of the range
FrRenaissance Capital's April IPO Market Update
FrSPAC Quantum Leap Acquisition prices $200 million IPO, targeting AI, quantum computing, and blockchain
FrSPAC CH4 Natural Solutions prices $200 million IPO, targeting businesses with real-asset footprints
FrHemab Therapeutics prices upsized IPO at $18, the high end of the range
DoAmmunition manufacturer First Breach files for a direct listing on the Nasdaq
DoExploration-stage mining company Silver Bow Mining prices upsized IPO at the $11.50 midpoint
DoCoagulation disorder biotech Hemab Therapeutics Holdings ups shares offered by 27% ahead of $255 million IPO
DoSPAC Forefront Tech Holdings Acquisition prices $100 million IPO, targeting AI and robotics
DoSPAC General Catalyst Global Resilience Merger prices $350 million IPO, targeting aerospace and defense
DoSPAC Mountain Crest Acquisition 6 prices $60 million IPO, led by Suying Liu
DoSPAC West Enclave Merger prices $100 million IPO, targeting Latin America-focused businesses
DoPulmonary fibrosis biotech Avalyn Pharma prices upsized IPO at $18, the high end of the range
DoSPAC GSR V Acquisition files for a $200 million IPO, targeting companies with leading market positions
MiSPAC Aussie Aussie Acquisition files for a $100 million US IPO, targeting defensible market positions
MiPulmonary fibrosis biotech Avalyn Pharma increases shares offered by 41% ahead of $283 million IPO
MiBill Ackman's closed-end fund Pershing Square USA prices $5 billion IPO at $50 per share; manager Pershing Square Inc. also set to trade on the NYSE
MiIPO Weekly Weigh-in: Kraken's pre-IPO haircut?
MiSPAC Collective Acquisition II prices $220 million IPO, targeting finance, defense technology, and AI
DiMalaysian fintech AsiaFIN Holdings revises terms, changes underwriter ahead of $19 million US IPO
DiExploration-stage mining company Rare Earths Americas sets terms for $50 million IPO
DiSPAC Plutonian Acquisition II prices $100 million IPO, targeting energy storage and telecom